Literature DB >> 241799

Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats.

D R Varma, D Goldbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 241799     DOI： 10.1111/j.2042-7158.1975.tb09406.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  5 in total

Review 1.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 2.  Cardiovascular pharmacology of cannabinoids.

Authors:  P Pacher; S Bátkai; G Kunos
Journal:  Handb Exp Pharmacol       Date:  2005

Review 3.  Blood pressure regulation by endocannabinoids and their receptors.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Neuropharmacology       Date:  2005-02-19       Impact factor: 5.250

4.  BRL 13776: a novel antihypertensive agent with interesting monoamine depleting properties.

Authors:  J Melrose; M G Palfreyman; R H Poyser; R L Whiting
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

Review 5.  Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance.

Authors:  Barbara Malinowska; Marek Toczek; Anna Pędzińska-Betiuk; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.